Replies to post #70886 on DNAprint Genomics (DNAG)

[jkids210]

I took at look at some of the 10k back when the company first started. Previous management really sucked. It seemed like Richard did make some changes for the company. When he first came onboard he didn't even get paid, he got DNAG shares. At the time it increased to what 1.5 billion shares outstanding, so I guess the reverse split was needed. There has been good development since he came on board such as AncestryDNA, the Pharma with the EPO and CD59. It was also Richards idea to get into forensics to start generating revenues since drugs takes a while. The only bad thing he did was the dutchess financing.